Effects of dipyridamole in experimental atherosclerosis
- 1 July 1979
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 33 (3) , 315-327
- https://doi.org/10.1016/0021-9150(79)90183-7
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Prostacyclin-dependent differences in TXA2 formation by platelets from normal and atherosclerotic rabbitsAtherosclerosis, 1979
- Antiplatelet TherapyNew England Journal of Medicine, 1978
- Prostaglandins and ThromboxanesAnnual Review of Biochemistry, 1978
- DIPYRIDAMOLE AND OTHER PHOSPHODIESTERASE INHIBITORS ACT AS ANTITHROMBOTIC AGENTS BY POTENTIATING ENDOGENOUS PROSTACYCLINThe Lancet, 1978
- Homocystine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis.Journal of Clinical Investigation, 1976
- Transport and metabolism of adenosine in human blood plateletsBiochimica et Biophysica Acta (BBA) - Biomembranes, 1976
- CHANGES OF CYCLIC‐AMP AND CYCLIC‐AMP PHOSPHODIESTERASE IN THE PROGRESSION AND REGRESSION OF EXPERIMENTAL ATHEROSCLEROSISAnnals of the New York Academy of Sciences, 1976
- ROLE OF THE PLATELET IN ATHEROGENESIS*Annals of the New York Academy of Sciences, 1976
- Hyperreactive Arterial Endothelial Cells in Atherogenesis and Cyclic AMP Phosphodiesterase Inhibitor in Prevention and Treatment of Atherosclerotic DisordersJapanese Heart Journal, 1975
- Platelets, Thrombosis and DrugsDrugs, 1975